Across Europe , interest surrounding copyright as a treatment for psychiatric conditions is surging. While previously viewed primarily as an veterinary agent, its efficacy in treating mood disorders, particularly chronic cases, is driving a considerable alteration in clinical practice . Despite this, availability stays complex and varies widely wit